The company was the prime supplier of saline to govt hospitals after the state banned Paschim Banga Pharmaceuticals ... treatment of dehydration, a paracetamol infusion and antibiotic drugs ...

Mortgage Cadence offers a cloud-based digital lending platform designed to streamline the mortgage lifecycle. With solutions that cover the entire lending process — from borrower point-of-sale ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...

ONAPGO, a subcutaneous infusion device, treats motor fluctuations in advanced Parkinson's disease and launches in the U.S. in 2025. Supernus Pharmaceuticals has announced the FDA approval of ...

Vertex Pharmaceuticals VRTX has outperformed the market over the past 20 years by 12.12% on an annualized basis producing an average annual return of 20.47%. Currently, Vertex Pharmaceuticals has ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a ...

CHATHAM, N.J., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and ...

The National Pharmaceutical Pricing Authority (NPPA ... 2023 fixing the ceiling price of Contrapaque 300 mg infusion 100 ml and Contrapaque 30 mg injection 20 ml containing iohexol injection 300 mg ...

It is fourth time lucky for Supernus Pharmaceuticals (Nasdaq: SUPN), as its Parkinson’s specialist finally receives US approval for Onapgo (apomorphine hydrochloride). The company plans to launch the ...

Intas Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) to conduct the Phase I clinical trial of ...